EP1824558B1 - Vorrichtung für die elektro-inhibition der gesichtsmuskeln - Google Patents

Vorrichtung für die elektro-inhibition der gesichtsmuskeln Download PDF

Info

Publication number
EP1824558B1
EP1824558B1 EP05785600.7A EP05785600A EP1824558B1 EP 1824558 B1 EP1824558 B1 EP 1824558B1 EP 05785600 A EP05785600 A EP 05785600A EP 1824558 B1 EP1824558 B1 EP 1824558B1
Authority
EP
European Patent Office
Prior art keywords
electrodes
cloth
level
conductive
face
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP05785600.7A
Other languages
English (en)
French (fr)
Other versions
EP1824558A1 (de
Inventor
Pierre Rigaux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cefaly Technology SPRL
Original Assignee
Cefaly Technology SPRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34933128&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP1824558(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cefaly Technology SPRL filed Critical Cefaly Technology SPRL
Priority to EP05785600.7A priority Critical patent/EP1824558B1/de
Publication of EP1824558A1 publication Critical patent/EP1824558A1/de
Application granted granted Critical
Publication of EP1824558B1 publication Critical patent/EP1824558B1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0452—Specially adapted for transcutaneous muscle stimulation [TMS]
    • A—HUMAN NECESSITIES
    • A45—HAND OR TRAVELLING ARTICLES
    • A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D44/00—Other cosmetic or toiletry articles, e.g. for hairdressers' rooms
    • A45D44/22—Face shaping devices, e.g. chin straps; Wrinkle removers, e.g. stretching the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0472—Structure-related aspects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0472—Structure-related aspects
    • A61N1/0492—Patch electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/328—Applying electric currents by contact electrodes alternating or intermittent currents for improving the appearance of the skin, e.g. facial toning or wrinkle treatment

Definitions

  • the present invention relates to an apparatus for electrical inhibition or "electro-inhibition" to obtain the relaxation of certain muscles of the upper face.
  • Wrinkles can be due to a multitude of factors such as age, sun damage, etc., but they are mostly due to mimicry, that is to say, repeated muscle contractions (expression of joy, anger, sadness, fear, astonishment, etc.). We therefore speak of "expression lines”. These wrinkles that appear mainly in the upper half of the face are due to the interactions between the skin and the underlying muscles. We know in particular the vertical wrinkles of the forehead, the wrinkles of the corner of the eyes called “crow's feet", the horizontal wrinkles of the forehead, etc.
  • wrinkles of the forehead are caused by a prolonged tension inducing a chronic contracture is one of the three muscles of the upper of the face which are the frontal muscle (frontalis), the double eyebrow muscle (corrugator) and the pyramidal muscle of the nose (procerus), or several of them at the same time.
  • the pyramidal muscle is a small, muscular fasciculus located on the upper part of the back of the nose and between the eyes. It extends between the fascia covering the lower part of the clean bone of the nose and the deep face of the skin of the inter-superciliary region. It causes the eyebrows to draw down and the midline, creating folds on the root of the nose. It intervenes in the frown of the eyebrows, the expression of concentration or simply to reduce glare in case of bright light.
  • the frontal muscle is a flat muscle located under the skin of the forehead. It is born from the anterior edge of the epicranial aponeurosis, its fleshy fibers descend and attach to the deep surface of the skin of the superciliary and interbrowbone regions. It raises the skin of the eyebrows and produces the horizontal wrinkles and folds of the forehead.
  • the two eyebrow muscles are extended on either side of the glabella along the inner part of the brow bone. They are born from the inner end of the brow bone and move outward along the arch and end at the deep face of the eyebrow skin. They draw the eyebrows towards the midline and are responsible for the vertical wrinkles and folds of the glabella.
  • Botox ® botulinum toxin type A, derived from the bacterium Clostridium botulinum (known under the trade name Botox ® ). Botox ® is injected in low doses into a specific muscle that becomes paralyzed and can no longer contract. These products have a duration of action of a few months.
  • Botox ® injections are found in the general circulation of the patient.
  • a specific side effect is an observation of unwanted paralysis of the muscles of swallowing (dysphagia).
  • muscle electro-stimulation is well known.
  • the US patent US Patent 4,957,480 describes a method of toning the muscles and tissues of the face by stimulation of the motor nerves and consecutive contraction of the muscles of the face, by applying galvanic currents of predetermined amplitude, frequency and polarity through humidified electrodes by means of a liquid solution of positively and negatively charged particles for introduction into the tissues to nourish the muscles and surrounding facial tissues. It is known from this document that it is possible in this way, by a particular positioning of the electrodes directly on the muscle, to obtain a fatigue, and hence a relaxation, for example of the frontal muscle.
  • the currents are between 300 and 640 ⁇ A with a frequency between 30 and 99 Hz, with alternating polarization and a duration of application of between 1 and 4 seconds, or even 10 seconds.
  • the electrical parameters used generate a fatigue of work, similar to the voluntary fatigue of the muscle, which produces only a weak relaxation if not null. This is the classic framework of electro-stimulation with frequencies below 100 Hz to produce short contractions.
  • the US patent US Patent 3,709,228 describes an apparatus for electro-stimulation of the nerves, and thus of the muscles, of the face of a user, comprising a support resting on the nose and ears and carrying arms deformable that can extend in opposite directions and carrying at their end skin contact electrodes.
  • a first electrode is positioned to stimulate the frontal branch of the facial nerve.
  • a second electrode is positioned to stimulate the maxillary branch of the facial nerve.
  • a third electrode is positioned to stimulate the mandibular branch of the facial nerve. This document does not suggest electrode positioning at the inter-eyebrow gap.
  • the present invention aims to provide an apparatus for obtaining, by the action of an electric current, a loosening of one or more muscles of the upper part of the face, in particular the frontal muscle ( frontalis ), the two muscles eyebrows ( corrugator ) and the pyramidal muscle of the nose ( procerus ).
  • Claims 2 to 12 specify preferred embodiments of the device of Claim 1.
  • the figure 1 schematically represents a front view of the electro-muting device according to a first preferred embodiment of the present invention, placed on the head of a user.
  • Figure 2 represents a rear view of the device of the figure 1 .
  • the figure 3 represents a view from above for the device of the figure 1 .
  • the figure 4 represents a view in section and from above of the front part of the device of the figure 1 .
  • the figure 5 schematically represents a front view (without the electrode) of the electro-muting device according to a second preferred embodiment of the present invention, placed on the head of a user.
  • the figure 6 represents a rear view of the dipositif of the figure 5 , as well as a detailed view of the double electrode placed on its support.
  • the figure 7 represents different views of the electrode of the figure 6 .
  • the innovative principle at the base of the invention is to produce an inhibition of the three aforementioned muscles in the upper part of the face by means of the application of an electric current on only one of these muscles, namely the pyramidal.
  • the specific placement of the electrodes makes it possible, by inhibiting the pyramidal muscle, to obtain reflex relaxation actions on the other muscles of the upper part of the face. It is therefore a device aimed at the opposite effect of that sought in electro-stimulation, since the aim is the relaxation of the muscles and not their contraction.
  • two small electrodes 2 are positioned parallel to each other at the level of the inter-eyebrow space called glabella (glabella), so as to pass the electrical inhibition current through the pyramidal muscle of the nose.
  • the electrodes 2 are supported by a headband 1.
  • These electrodes 2 have essentially a rectangular shape whose size is more or less 25 mm by 5 mm and are spaced apart from each other by a distance of 3 to 15 mm.
  • the current applied to the electrodes 2 consists of electrical pulses known to be able to trigger action potentials (PA) at the level of the motor nerves. These are rectangular pulses with a width between 30 and 100 ⁇ s and an intensity ranging from 0 to 30 mA (3) . The use of this type of pulse leads to less excitation of the pain fibers than the use of longer pulses. But any other type of pulse sufficient to trigger a PA on motor neurons could be used.
  • PA action potentials
  • an essential characteristic of the invention is that the applied current advantageously uses pulses having a frequency greater than 100 Hz, which generates a very rapid electrical fatigue of the pyramidal muscle (4, 5) .
  • pulses having a frequency greater than 100 Hz, which generates a very rapid electrical fatigue of the pyramidal muscle (4, 5) .
  • This pulse frequency being kept constant, in a few tens of seconds, the pyramidal muscle becomes inexcusable, loses its tone and thus relaxes completely (7) .
  • Motoneuron excitation of the pyramidal muscle also produces relaxation of its antagonist muscle - the frontal muscle - via the reciprocal inhibition reflex (8) .
  • the electrical impulses at the level of a muscle excite not only the motoneurons of this muscle but also the proprioceptive afferent fibers of this muscle.
  • the excitation of the latter inhibits the motor neurons of the antagonist muscle (9,10) .
  • the electrodes 2 being located at the level of the internal tendons of the eyebrow muscles, the current excites the afferent nerves of these tendons, that is to say those leaving the Golgi tendon corpuscles. These tendinous afferences being inhibitory of the motor neurons of their muscle, namely the double eyebrow, their excitation by the electric impulses produces a loosening of the muscle (11,12) .
  • the electrical frequencies are higher (at least 120 or 150 Hz) and the duration of application much longer (typically greater than 60 s), as in the patent US Patent 4,957,480 . It thus occurs, not a work fatigue, but a so-called intense electric fatigue ( 4,6 ).
  • the electrical activity, characterized by the rest and action potentials, on the muscle fibers disappears by accumulation of potassium ions (K + ) in extracellular.
  • K + potassium ions
  • the electromechanical coupling of the muscular activity is broken by the disappearance of the electric potential of the fibers. This results in a total suspension of the mechanical activity of the muscle and therefore a complete relaxation, the muscle being in a reversible state of electromechanical stunting. Obtaining this state is also avoided and contraindicated in conventional electro-stimulation. It can only occur through the specific electrical parameters of the present invention. It is observed neither in electro-stimulation, nor during voluntary contractions.
  • the entire system allowing electro-inhibition is included in a single device 1.
  • this one is designed similarly to a spectacle frame that rests on the nose at the front and on the ears at the back thanks to two adequate branches.
  • the electronic circuit 3 and the power supply 4 in the form of batteries are placed in a hollow front part of the device, at the level of hatches 5.
  • the electrodes on the internal and medial face of the front part 6 are configured to position themselves correctly in the inter-eyebrow space when the device is set up on a subject.
  • a "double" electrode 2A has been designed, that is to say in which the two conducting poles 2 are carried by a single structure.
  • this arrangement has the convenience of having to place only one electrode, rather than two, as is usually the case in all conventional electrotherapy techniques.
  • the electrode 2A has a shape and a size adapted to the area to be treated, that is to say which allows to cover the glabella area and to inhibit the pyramidal muscle.
  • the electrode 2A comprises a essentially rectangular piece of fabric 21, the longest side to be positioned substantially vertically, and which optionally has cut corners at its lower part placed on the top of the nose and a rounded upper side placed at the forehead ( figure 7 ).
  • the piece of fabric 21 which constitutes the mechanical support of the electrode is impregnated with two conductive silver zones 2 which pass through the thickness of the fabric.
  • the fabric becomes conductive between its inner face, which is placed on the side of the skin and its outer face, which is placed on the side of the contact pads at the electrical device.
  • the conduction between the electrical apparatus and the electrodes is provided by a cable or a snap-button, the external surface of the electrode being otherwise non-conductive.
  • the outer surfaces of the poles of the electrode are conductive, which allows two conductive pads 25 of the device to come into direct contact with the poles.
  • Optimum conduction between the conductive areas 2 and the skin of the user is provided by two areas of conductive adhesive gel 22 covering said conductive areas on the inner face of the electrode, in contact with the skin.
  • these two zones of conductive gel will extend over the entire length of the piece of fabric and, from the outer lateral edge, over a width sufficient to completely cover the corresponding silver zone 2 ( figure 7 ).
  • An advantageous alternative to silver impregnation is to make two openings in the electrode tissue to allow the pads mentioned above to come into direct contact with the gel.
  • the insulation between the two poles 2 of the electrode 2A is provided by a central zone 23 devoid of self-adhesive conductive gel 22.
  • the electrode 2A is provided with a non-conductive pin-shaped piece 24 to ensure the mechanical engagement of the support device and the electrode 2A and to allow the two contact pads 25 to come exactly on the two conductive outer zones of the electrode.
  • the electronic circuit is located in the central zone of the support device 1. From this circuit, the two blades or contact pads 25 come to be applied on the two conductive outer surfaces of the aforementioned electrode. 2A, that is to say the two areas of the electrode impregnated with conducting silver.
  • the central portion of the housing is recessed and provided with a housing 26 which allows the interlocking "pin” 24 of the electrode.
  • This housing 26 is wide in its lower part and narrow in its upper part, this allowing the user to perform very easily the interlocking between the support device and the electrode.
  • the pin 24 advantageously comprises a short rod terminated by a rounded bulging head which allows it to come to lock in the narrow part of the housing 26 of the support device 1 ( figure 6 ).
  • the fabric support 21 has dimensions of 37 mm ⁇ 22 mm
  • the electrodes have as the dimensions 21 mm x 7 mm
  • the central zone 23 between the electrodes free of self-adhesive gel is 5 mm wide
  • the pin 24 is anchored at a distance of 16.5 mm from the lower edge of the part 2A.
  • the stability of the support device 1 in the form of a spectacle frame is provided by three points, on the one hand the two branches resting on the ears and on the other hand the electrode stuck on the glabella. This is different from a classic eyeglass frame whose third point of stability is provided by the nose saddle or pads that come to rest on the nose.
  • the latter system can not be suitable for the device of the invention because the variations, from one individual to another, the shape and size of the nose do not always allow the contact pads to come to be placed exactly at the level conductive surfaces of the electrode.
  • the device of the invention still has the advantage of being inexpensive, easy to use and brief (typically less than 5 minutes), particularly in user's home and not to induce side effects that are found in injection techniques (allergy, redness, edema, presence of an artificial implant, etc.).

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Electrotherapy Devices (AREA)

Claims (12)

  1. Vorrichtung für die Elektro-Inhibition der Gesichtsmuskeln, umfassend:
    - eine Armatur für den Kopf eines Benutzers (1) mit zwei zur Anordnung auf jeder Seite des oberen Nasenbereichs im Bereich der Glabella geeignete Kontaktelektroden (2), welche zu einer einzigen Elektrodenstruktur gehören (2A),
    - eine elektronische Schaltung (3) zur Erzeugung elektrischer Impulse mit niedriger Spannung an den Elektroden (2) sowie eine Gleichstrom-Spannungsversorgung (4),
    dadurch gekennzeichnet, dass:
    - die Elektrodenstruktur (2A) ein Stoffstück (21) als Träger der Elektroden (2) umfasst, wobei letztere auf der Innenseite, d.h. die Seite, die mit der Haut des Benutzers in Berührung kommen soll, durch ein selbstklebendes leitfähiges Gel (22) beschichtet sind, und
    - die beiden Elektroden (2) sich als zwei leitfähige versilberte Bereiche darstellen, die das Stoffstück (21) imprägnieren, wobei dieses sowohl auf der Innen- als auch auf der Außenseite, d.h. auf der die Kontaktlinsen (25) der Vorrichtung berührenden Seite, leitfähig ist.
  2. Vorrichtung nach Anspruch 1, dadurch gekennzeichnet, dass im Stoffstück (21) zwei Öffnungen vorgesehen sind, die es den Kontaktlinsen (25) ermöglichen, unmittelbar mit dem leitfähigen Gel (22) oder einer zwischen dem Stoff und dem Gel angeordneten, evtl. mit einer Silberschicht beschichteten Kohlenstoffschicht in Berührung zu treten.
  3. Vorrichtung nach Anspruch 1, dadurch gekennzeichnet, dass das leitfähige Gel (22) in Gestalt von Bereichen, die sich über die ganze Länge des Stoffstückes (21) sowie vom lateralen Außenrand über eine zur vollständigen Beschichtung der beiden Elektroden (2) ausreichende Länge erstrecken, aufgetragen wird.
  4. Vorrichtung nach Anspruch 3, dadurch gekennzeichnet, dass das Stoffstück (21) einen nicht mit leitfähigem Gel beschichteten Mittelbereich aufweist, um die Elektroisolierung zwischen den Elektroden (2) zu gewährleisten.
  5. Vorrichtung nach Anspruch 1, dadurch gekennzeichnet, dass die einzige Stoffstruktur eine im Wesentlichen rechteckige Form aufweist, wobei die Längsseite bzw. die Länge des Rechtecks im Wesentlichen senkrecht angeordnet werden und auf der die Elektroden (2) durch einen Abstand von 3 - 15 mm voneinander getrennt sind, wobei die Struktur eventuell abgeschräge Ecken im unteren Bereich, der auf der Oberseite der Nase angebracht wird und eine abgerundete Oberseite, die auf der Stirn angebracht wird, aufweist.
  6. Vorrichtung nach einem der Ansprüche 1 - 5, dadurch gekennzeichnet, dass die einzige Elektrodenstruktur (2A) mit einem Zylinderförmigen, nichtleitfähigen Stück (24) versehen ist, um das mechanische Ineinandergreifen der Struktur (2A) in die Armatur (1) unter Inberührungbringen der Kontaktlinsen (25) mit den jeweiligen Elektroden (2) zu gewährleisten.
  7. Vorrichtung nach Anspruch 6, dadurch gekennzeichnet, dass das Zylinderförmige Stück (24) eine kurze Stange, auf der ein rundes, konvexes Kopfstück montiert ist, aufweist, die geeignet ist, im engen Teil eines Gehäuses (26) der Armatur (1) fixiert zu werden, dessen Unterteil breiter als sein Oberteil ist.
  8. Vorrichtung nach einem der Ansprüche 1 - 7, dadurch gekennzeichnet, dass sie Fixier- und Blockiermittel (7) in Gestalt einer Brillenfassung mit einer VorderArmatur auf der Nase im Bereich der einzigen Elektrodenstruktur (2A) und zwei hinter den Ohren angeordnete Bügel umfasst.
  9. Vorrichtung nach einem der Ansprüche 1 - 7, dadurch gekennzeichnet, dass sie Fixier- und Blockiermittel (7) in Gestalt eines Haarreifes zur Positionierung auf der Stirn umfasst.
  10. Vorrichtung nach einem der Ansprüche 1 - 7, dadurch gekennzeichnet, dass sie Fixier- und Blockiermittel (7) in Gestalt einer bogenförmigen Armatur, die sich auf der Mittellinie des Schädels abstützt, umfasst.
  11. Vorrichtung nach einem der Ansprüche 1 - 7, dadurch gekennzeichnet, dass sie Fixier- und Blockiermittel (7) in Gestalt eines Helms aus leichtem Stoff umfasst.
  12. Vorrichtung nach einem der Ansprüche 8 - 11, dadurch gekennzeichnet, dass die Blockiermittel derart angeordnet sind, dass, wenn sie sich in der geschlossenen bzw. offenen Position befinden, das System auch als geschlossener bzw. offener Schalter der elektronischen Schaltung (3) fungiert.
EP05785600.7A 2004-12-14 2005-09-07 Vorrichtung für die elektro-inhibition der gesichtsmuskeln Active EP1824558B1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP05785600.7A EP1824558B1 (de) 2004-12-14 2005-09-07 Vorrichtung für die elektro-inhibition der gesichtsmuskeln

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04447276A EP1671670A1 (de) 2004-12-14 2004-12-14 Vorrichtung zur teilweisen elektrischen Lähmung von Gesichtsmuskeln
EP05785600.7A EP1824558B1 (de) 2004-12-14 2005-09-07 Vorrichtung für die elektro-inhibition der gesichtsmuskeln
PCT/BE2005/000135 WO2006063417A1 (fr) 2004-12-14 2005-09-07 Appareil pour l'electro-inhibition des muscles de la face

Publications (2)

Publication Number Publication Date
EP1824558A1 EP1824558A1 (de) 2007-08-29
EP1824558B1 true EP1824558B1 (de) 2013-11-06

Family

ID=34933128

Family Applications (2)

Application Number Title Priority Date Filing Date
EP04447276A Withdrawn EP1671670A1 (de) 2004-12-14 2004-12-14 Vorrichtung zur teilweisen elektrischen Lähmung von Gesichtsmuskeln
EP05785600.7A Active EP1824558B1 (de) 2004-12-14 2005-09-07 Vorrichtung für die elektro-inhibition der gesichtsmuskeln

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP04447276A Withdrawn EP1671670A1 (de) 2004-12-14 2004-12-14 Vorrichtung zur teilweisen elektrischen Lähmung von Gesichtsmuskeln

Country Status (10)

Country Link
US (1) US8914123B2 (de)
EP (2) EP1671670A1 (de)
JP (1) JP2008522676A (de)
KR (1) KR20070095287A (de)
CN (1) CN101072602B (de)
AU (1) AU2005316218A1 (de)
BR (1) BRPI0517186B8 (de)
CA (1) CA2591667C (de)
MX (1) MX2007007076A (de)
WO (1) WO2006063417A1 (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2092951A1 (de) 2008-02-20 2009-08-26 Stx-Med Sprl Gerät zur elektrotherapeutischen Behandlung von Spannungskopfschmerzen
AU2008365106B2 (en) * 2008-12-11 2015-02-05 Bio-Medical Research Limited Facial stimulation apparatus
WO2012082960A2 (en) 2010-12-14 2012-06-21 The Regents Of The University Of California Devices, systems and methods for the treatment of medical disorders
WO2012082961A2 (en) 2010-12-14 2012-06-21 The Regents Of The University Of California Extracranial implantable devices, systems and methods for the treatment of medical disorders
AU2010303583B2 (en) * 2009-10-05 2015-08-06 The Regents Of The University Of California Systems, devices and methods for the treatment of neurological disorders and conditions
US8747383B2 (en) * 2009-12-18 2014-06-10 University Medical Pharmaceuticals Corp. Process and system for iontophoretic wrinkle reduction
US8702584B2 (en) 2010-05-12 2014-04-22 Cefaly Technology Sprl Neurostimulation method to induce relaxation or sleep
WO2012068247A1 (en) 2010-11-16 2012-05-24 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for treatment of dry eye
US9821159B2 (en) 2010-11-16 2017-11-21 The Board Of Trustees Of The Leland Stanford Junior University Stimulation devices and methods
WO2012075192A2 (en) 2010-11-30 2012-06-07 The Regents Of The University Of California Pulse generator for cranial nerve stimulation
CN103269746B (zh) 2010-12-13 2015-07-29 Stx医疗私人有限公司 用于外部枕神经刺激的头带
BE1020458A3 (fr) 2012-01-13 2013-10-01 Stx Med Sprl Appareil electronique autonome et dipositif de fixation de celui-ci sur une electrode localisee au niveau de la tete pour une utilisation en position couchee du patient.
GB201211703D0 (en) 2012-07-02 2012-08-15 Charles Nduka Plastic Surgery Ltd Biofeedback system
US9399126B2 (en) 2014-02-27 2016-07-26 Thync Global, Inc. Methods for user control of neurostimulation to modify a cognitive state
US10537703B2 (en) 2012-11-26 2020-01-21 Thync Global, Inc. Systems and methods for transdermal electrical stimulation to improve sleep
US9440070B2 (en) 2012-11-26 2016-09-13 Thyne Global, Inc. Wearable transdermal electrical stimulation devices and methods of using them
US10814131B2 (en) 2012-11-26 2020-10-27 Thync Global, Inc. Apparatuses and methods for neuromodulation
US10485972B2 (en) 2015-02-27 2019-11-26 Thync Global, Inc. Apparatuses and methods for neuromodulation
EP2967817B1 (de) 2013-03-12 2021-03-10 Oculeve, Inc. Implantateinführungsvorrichtungen und -systeme
CN105307718B (zh) 2013-04-19 2018-05-11 奥库利维公司 鼻刺激装置和方法
KR102249019B1 (ko) * 2013-06-28 2021-05-10 스탑파킨슨 헬스케어 시스템즈 엘엘씨 전기-자극 장치
US10293161B2 (en) 2013-06-29 2019-05-21 Thync Global, Inc. Apparatuses and methods for transdermal electrical stimulation of nerves to modify or induce a cognitive state
EP3013414B1 (de) 2013-06-29 2018-09-19 Cerevast Medical Inc. Transdermale elektrische stimulationsvorrichtungen und verfahren zur modifizierung oder induzierung eines kognitiven zustands
FR3012741B1 (fr) * 2013-11-07 2017-10-06 Ad Rem Tech Appareil de stimulation electrique du visage
AU2015223184B2 (en) 2014-02-25 2020-07-02 Oculeve, Inc. Polymer formulations for nasolacrimal stimulation
JP6306926B2 (ja) * 2014-04-14 2018-04-04 株式会社ジンズ アイウエア
WO2015179281A2 (en) 2014-05-17 2015-11-26 Thync, Inc. Methods and apparatuses for the application of ensemble waveforms using transdermal neurostimulation
US9333334B2 (en) 2014-05-25 2016-05-10 Thync, Inc. Methods for attaching and wearing a neurostimulator
KR20170063440A (ko) 2014-05-25 2017-06-08 하이인 에쿼티 인베스트먼트 펀드 엘.피. 웨어러블 경피 신경자극기들
US10130809B2 (en) 2014-06-13 2018-11-20 Nervana, LLC Transcutaneous electrostimulator and methods for electric stimulation
US9782584B2 (en) 2014-06-13 2017-10-10 Nervana, LLC Transcutaneous electrostimulator and methods for electric stimulation
ES2792856T3 (es) 2014-07-25 2020-11-12 Oculeve Inc Patrones de estimulación para tratar la sequedad ocular
JP6720146B2 (ja) * 2014-09-17 2020-07-08 ネウロリーフ リミテッド 神経刺激および身体パラメータの感知のためのヘッドセット
US10207108B2 (en) 2014-10-22 2019-02-19 Oculeve, Inc. Implantable nasal stimulator systems and methods
CA2965514A1 (en) 2014-10-22 2016-04-28 Oculeve, Inc. Contact lens for increasing tear production
AU2015335776B2 (en) 2014-10-22 2020-09-03 Oculeve, Inc. Stimulation devices and methods for treating dry eye
US10426945B2 (en) 2015-01-04 2019-10-01 Thync Global, Inc. Methods and apparatuses for transdermal stimulation of the outer ear
US11534608B2 (en) 2015-01-04 2022-12-27 Ist, Llc Methods and apparatuses for transdermal stimulation of the outer ear
US10258788B2 (en) 2015-01-05 2019-04-16 Thync Global, Inc. Electrodes having surface exclusions
EP3302682A1 (de) 2015-05-29 2018-04-11 Cerevast Medical Inc. Verfahren und vorrichtung zur transdermalen elektrischen stimulation
CN105288845A (zh) * 2015-11-20 2016-02-03 陕西巴赫曼健康产品有限公司 一种舒肌止痛贴治疗仪
CN105288846A (zh) * 2015-11-20 2016-02-03 陕西巴赫曼健康产品有限公司 一种头痛舒眠治疗仪
US10426958B2 (en) 2015-12-04 2019-10-01 Oculeve, Inc. Intranasal stimulation for enhanced release of ocular mucins and other tear proteins
WO2017106878A1 (en) 2015-12-18 2017-06-22 Thync Global, Inc. Apparatuses and methods for transdermal electrical stimulation of nerves to modify or induce a cognitive state
US9956405B2 (en) 2015-12-18 2018-05-01 Thyne Global, Inc. Transdermal electrical stimulation at the neck to induce neuromodulation
CN105763173B (zh) * 2016-02-18 2018-12-21 广东宝莱特医用科技股份有限公司 一种电脉冲发生装置
US10252048B2 (en) 2016-02-19 2019-04-09 Oculeve, Inc. Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
UY36934A (es) 2016-03-31 2017-11-30 Medecell S A Proceso para establecer un protocolo de electroestimulación para el control de cefaleas, y el respectivo equipo portátil de electroestimulación para el control de cefaleas utilizando el referido protocolo
AU2017260237A1 (en) 2016-05-02 2018-11-22 Oculeve, Inc. Intranasal stimulation for treatment of meibomian gland disease and blepharitis
US10646708B2 (en) 2016-05-20 2020-05-12 Thync Global, Inc. Transdermal electrical stimulation at the neck
KR20190124698A (ko) 2016-12-02 2019-11-05 오큘레브, 인크. 건성안 예측 및 치료 권고를 위한 장치 및 방법
JP1602423S (de) * 2017-01-19 2018-04-23
EP3576835B1 (de) * 2017-02-02 2023-08-02 Flow Neuroscience AB Kopfhörer für transkranielle gleichstromstimulation, tdcs und system mit dem kopfhörer
DE202018001803U1 (de) 2017-05-19 2018-06-27 Cefaly Technology Sprl Externe Trigeminusnervenstimulation für die Akutbehandlung von Migräneattacken
US11141089B2 (en) 2017-07-05 2021-10-12 Yusuf Ozgur Cakmak System for monitoring auditory startle response
USD855816S1 (en) * 2018-02-12 2019-08-06 Wat Medical Technology Inc. Anti-migraine device
KR102128927B1 (ko) * 2018-04-12 2020-07-01 (주)더마테크 물리력 기반 피부관리장치, 그 장치의 구동방법
US11278724B2 (en) 2018-04-24 2022-03-22 Thync Global, Inc. Streamlined and pre-set neuromodulators
JP7285632B2 (ja) * 2018-10-30 2023-06-02 ヤーマン株式会社 刺激付与装置
USD908230S1 (en) * 2019-01-07 2021-01-19 Apex Neuro Holdings, Inc. Transcutaneous neuromodulation device
USD922592S1 (en) * 2019-05-31 2021-06-15 Apex Neuro Holdings, Inc. Transcutaneous neuromodulation device
USD922593S1 (en) * 2019-05-31 2021-06-15 Apex Neuro Holdings, Inc. Transcutaneous neuromodulation device
JP7177015B2 (ja) * 2019-07-19 2022-11-22 ヤーマン株式会社 目元用美容マスク
CN116547034A (zh) * 2020-12-11 2023-08-04 株式会社资生堂 美容设备以及使用该美容设备的美容方法
WO2023224636A1 (en) 2022-05-20 2023-11-23 Spark Biomedical, Inc. Devices for treating stress and improving alertness using electrical stimulation
US12017068B2 (en) 2022-05-27 2024-06-25 Spark Biomedical, Inc. Devices and methods for treating motion sickness using electrical stimulation

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2782786A (en) * 1955-10-10 1957-02-26 Louis R Krasno Electrocardiograph electrode with absorbent contact surface
US3464416A (en) * 1967-08-25 1969-09-02 Williams Instruments Sleep inducing method and headpiece
US3620219A (en) * 1969-05-07 1971-11-16 Donald E Barker Facial nerve stimulator
US3709228A (en) 1971-01-07 1973-01-09 D Barker Apparatus for facial stimulation
US3971387A (en) * 1975-03-21 1976-07-27 Mantell Michael J Electro-therapeutic face mask
US4165750A (en) * 1978-03-18 1979-08-28 Aleev Leonid S Bioelectrically controlled electric stimulator of human muscles
US4209234A (en) * 1978-06-02 1980-06-24 Mccooeye Donald E Defogging eye glasses
US4288222A (en) * 1980-02-19 1981-09-08 Kling Jane A Doll with removable organs
JPS56150554U (de) * 1980-04-10 1981-11-11
US4509521A (en) * 1983-01-31 1985-04-09 Barry Terrence J Headache relief method
JPS618027A (ja) * 1984-06-22 1986-01-14 株式会社　八木商店 人体装着用電極
US4841954A (en) * 1986-12-17 1989-06-27 Klasi, Nirmal S. Oculofacial massager
US4957480A (en) 1988-02-02 1990-09-18 Universal Health Products, Inc. Method of facial toning
JPH0440656U (de) * 1990-08-06 1992-04-07
US5450845A (en) * 1993-01-11 1995-09-19 Axelgaard; Jens Medical electrode system
US5496363A (en) 1993-06-02 1996-03-05 Minnesota Mining And Manufacturing Company Electrode and assembly
CN1098951A (zh) * 1993-08-20 1995-02-22 金国范 电子减皱面罩
US5527357A (en) * 1994-06-24 1996-06-18 Springer, Jr.; George E. Apparatus for toning facial tissue
US6233472B1 (en) * 1995-06-06 2001-05-15 Patient Comfort, L.L.C. Electrode assembly and method for signaling a monitor
US5913836A (en) * 1996-02-20 1999-06-22 Allied Health Association, Inc. Body toning method and apparatus
US5726916A (en) * 1996-06-27 1998-03-10 The United States Of America As Represented By The Secretary Of The Army Method and apparatus for determining ocular gaze point of regard and fixation duration
US6394953B1 (en) * 2000-02-25 2002-05-28 Aspect Medical Systems, Inc. Electrode array system for measuring electrophysiological signals
US6038464A (en) 1998-02-09 2000-03-14 Axelgaard Manufacturing Co., Ltd. Medical electrode
US6077237A (en) * 1998-11-06 2000-06-20 Adaboy, Inc. Headset for vestibular stimulation in virtual environments
JP2003500111A (ja) * 1999-05-20 2003-01-07 シー・ケスプ リミテッド ボディートリートメント装置
WO2001003638A1 (en) * 1999-07-12 2001-01-18 Dermispa Group, Inc. Massage and toning device and method of use
US20020161416A1 (en) * 2001-04-26 2002-10-31 Justine Huang Nerves and muscle stimulator
US20030045922A1 (en) * 2001-08-29 2003-03-06 Nancy Northrop Skin treatment method and apparatus
US20040260359A1 (en) * 2002-08-30 2004-12-23 Vincent Osrud Method for treating neurogenic illnesses responding to a low amperage electrical shock
US20040073129A1 (en) * 2002-10-15 2004-04-15 Ssi Corporation EEG system for time-scaling presentations
JP4238124B2 (ja) * 2003-01-07 2009-03-11 積水化学工業株式会社 硬化性樹脂組成物、接着性エポキシ樹脂ペースト、接着性エポキシ樹脂シート、導電接続ペースト、導電接続シート及び電子部品接合体
JP4151418B2 (ja) * 2003-01-17 2008-09-17 松下電工株式会社 美顔器
US20050038486A1 (en) * 2003-08-12 2005-02-17 Stephen Mulholland Apparatus and method for producing facelift-like effects on soft tissue
US20050187497A1 (en) * 2004-02-24 2005-08-25 Nguyen Thi Ngoc P. Electrical impulse apparatus for facial massage
US7559647B2 (en) * 2004-10-08 2009-07-14 Armando Curiel Apparatus, system and method for fastening articles to face or head

Also Published As

Publication number Publication date
CA2591667A1 (en) 2006-06-22
CN101072602B (zh) 2012-04-11
CN101072602A (zh) 2007-11-14
CA2591667C (en) 2015-03-17
KR20070095287A (ko) 2007-09-28
AU2005316218A1 (en) 2006-06-22
BRPI0517186B8 (pt) 2021-06-22
EP1671670A1 (de) 2006-06-21
WO2006063417A1 (fr) 2006-06-22
JP2008522676A (ja) 2008-07-03
BRPI0517186B1 (pt) 2018-03-13
BRPI0517186A (pt) 2008-09-30
US8914123B2 (en) 2014-12-16
MX2007007076A (es) 2007-06-26
EP1824558A1 (de) 2007-08-29
US20070276451A1 (en) 2007-11-29

Similar Documents

Publication Publication Date Title
EP1824558B1 (de) Vorrichtung für die elektro-inhibition der gesichtsmuskeln
Keller et al. Electrodes for transcutaneous (surface) electrical stimulation
EP2092951A1 (de) Gerät zur elektrotherapeutischen Behandlung von Spannungskopfschmerzen
FR3056113A1 (fr) Dispositif de traitement de la peau comprenant un modulateur d’impulsion
KR102633307B1 (ko) 뇌의 교차 단-펄스 전기 자극
JP2003339884A (ja) 顔面電気刺激装置
Rahmani et al. Chronic delivery of low-level exogenous current preserves retinal function in pigmented P23H rat
GB2160427A (en) Electrotherapeutic apparatus
FR2644070A1 (fr) Appareil pour le traitement des rides utilisant des ondes electriques unidirectionnelles de quelques micro-amperes et de frequence basse et des produits cosmetiques ionisables
KR102008393B1 (ko) 생체신호 피드백 기반의 마이크로 전류 발생장치, 이를 포함하는 탈모 방지 및 발모 마사지 장치
US8417347B2 (en) Method for achieving facial toning using selectively applied galvanic current
McDonnall et al. Restoration of blink in facial paralysis patients using FES
EP1216074B1 (de) Gerät zur elektrischen stimulation des lymphsystems
JP2011167316A (ja) 頭皮および毛髪の状態改善方法
JP2557988Y2 (ja) 毛根刺激器
JP3665632B2 (ja) イオン導入用の電気刺激装置及び電子美容器
EP2861298A1 (de) Vorrichtung für transdermalen und/oder intradermalen transport
FR2710542A1 (fr) Appareil pour l'application sur la peau d'un courant d'électrothérapie ou de traitement simple tel que la stimulation ou la détoxication.
EP0317451A1 (de) Elektronische Impulserzeugungsvorrichtung für einen Gesichtsapplikator und Verfahren zur Herstellung
JP3005990U (ja) 毛根刺激器
FR3039072B1 (fr) Appareil de traitement de la peau et procede de soin esthetique de la peau au moyen de cet appareil
KR200435473Y1 (ko) 두피 혈행개선장치
FR3012741A1 (fr) Appareil de stimulation electrique du visage
JPS6138594Y2 (de)
Sun et al. Bioelectricity and Its Application in Cosmetic Dermatology

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070414

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20121121

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602005041795

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: A61N0001320000

Ipc: A61N0001040000

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: A61N 1/04 20060101AFI20130417BHEP

Ipc: A61N 1/32 20060101ALI20130417BHEP

INTG Intention to grant announced

Effective date: 20130502

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

INTG Intention to grant announced

Effective date: 20130708

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CEFALY TECHNOLOGY SPRL

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: DE

Ref legal event code: R081

Ref document number: 602005041795

Country of ref document: DE

Owner name: CEFALY TECHNOLOGY SPRL, BE

Free format text: FORMER OWNER: STX-MED SPRL, ANGLEUR, BE

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 639011

Country of ref document: AT

Kind code of ref document: T

Effective date: 20131215

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: FRENCH

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602005041795

Country of ref document: DE

Effective date: 20140102

REG Reference to a national code

Ref country code: NL

Ref legal event code: T3

REG Reference to a national code

Ref country code: NL

Ref legal event code: T3

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 639011

Country of ref document: AT

Kind code of ref document: T

Effective date: 20131106

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131106

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131106

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131106

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140306

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131106

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131106

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131106

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140306

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131106

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602005041795

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131106

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131106

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131106

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131106

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131106

26N No opposition filed

Effective date: 20140807

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602005041795

Country of ref document: DE

Effective date: 20140807

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131106

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131106

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140907

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140930

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140930

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 11

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140907

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131106

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131106

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140207

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20050907

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131106

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 12

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 602005041795

Country of ref document: DE

Representative=s name: PRONOVEM-OFFICE VAN MALDEREN S.A, BE

Ref country code: DE

Ref legal event code: R082

Ref document number: 602005041795

Country of ref document: DE

Ref country code: DE

Ref legal event code: R081

Ref document number: 602005041795

Country of ref document: DE

Owner name: CEFALY TECHNOLOGY SPRL, BE

Free format text: FORMER OWNER: CEFALY TECHNOLOGY SPRL, HERSTAL, BE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 602005041795

Country of ref document: DE

REG Reference to a national code

Ref country code: FR

Ref legal event code: CA

Effective date: 20161118

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 13

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 14

REG Reference to a national code

Ref country code: BE

Ref legal event code: RC

Free format text: DETAILS PLEDGE: RIGHT OF PLEDGE, ETABLI

Name of requester: ELM PARK CAPITAL MANAGEMENT, LLC

Effective date: 20190715

REG Reference to a national code

Ref country code: BE

Ref legal event code: RF

Free format text: DETAILS PLEDGE: RIGHT OF PLEDGE, REMOVED

Name of requester: ELM PARK CAPITAL MANAGEMENT, LLC

Effective date: 20210517

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230523

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20230719

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20230810

Year of fee payment: 19

Ref country code: GB

Payment date: 20230720

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20230703

Year of fee payment: 19

Ref country code: DE

Payment date: 20230712

Year of fee payment: 19

Ref country code: BE

Payment date: 20230818

Year of fee payment: 19